Browse diseases

…making.Abstract SC35 Table 1Characteristics of 1004 people with HIV (PWH) according to treatment status at last visitAbstract SC35 …

…retion by PBMCs.Results 120 PWH and 20 controls were recruited. PWH (83.3% males) had a median age of 54 (IQR 47–59) years, and wer…

…tudy, performed between September 2022 - January 2026, eligible PWH were stratified into low, intermediate, or high VF risk as desc…

…a probability of 3.1% at 1 year (95%CI 0.45–20.2, figure 1B).17 PWH discontinued B/F/TAF during follow-up. The cumulative probabili…

…nfirmed in our study.Abstract P34 Table 1Characteristics of 640 PWH switching to DOR-based regimensAbstract P34 Table 2Unadjusted a…

…e frequently female (33.0% vs 18.8%), and PWID (15.2% vs 7.7%). PWH on OutR showed a longer treatment-experienced profile, with lon…

…H.Methods This was a longitudinal observational study including PWH ≥ 40 years attending Modena HIV Metabolic Clinic, Italy, from 2…

…1 and T2 with no differences between DTG and TAF.Conclusions In PWH already on TAF, stopping TAF does not have an impact on lipid p…

…d through multivariable Cox regressions.Results We included 615 PWH ( table 1). Overall, 39 VF occurred during a median follow-up o…

…t study including antiretroviral therapy (ART)-experienced PWH. PWH were divided into two groups (LA CAB+RPV) and oral dual therapy…

…0.97-1.35) (tables 2-3).Conclusions In virologically suppressed PWH, no evidence for a difference in treatment failure was observed…

…parallel sensitivity analyses using CVF-50.Results Overall, 490 PWH were included: 398 (81.2%) were males, with a median age of 52 …